Skip to content
Sign in

IMVT · NASDAQ

Immunovant (IMVT) Stock Price & Fundamentals

$797.38+0.49%+$3.86End-of-day price as of Oct 9, 2026

Immunovant (IMVT) closed at $797.38 on Oct 9, 2026, up 0.49% from the previous close of $793.52.

Share price, past year

1Y +6.46%

52-week range $726.52 – $871.88. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$797.38
Sep 30, 2026$795.25
Aug 31, 2026$821.34
Jul 31, 2026$832.71
Jun 30, 2026$827.94
May 29, 2026$804.11
Apr 30, 2026$787.64
Mar 31, 2026$805.38
Feb 27, 2026$838.60
Jan 30, 2026$806.30
Dec 31, 2025$800.22
Nov 28, 2025$804.53
Oct 31, 2025$734.97

Key statistics

Market cap
$164.47B
EPS (TTM)
−$2.81
Net income (TTM)
−$538.22M
Shares outstanding
206.3M
52-week range
$726.52 – $871.88

Immunovant's market cap is $164.47B, based on a share price of $797.38 and 206.3M shares outstanding as of Jun 30, 2026.

Financials

Immunovant's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.

Immunovant reported a net loss of $505.61M in fiscal 2026.

Company profile

Name
Immunovant, Inc.
Ticker
IMVT
Exchange
NASDAQ
Industry (SEC SIC)
Biological Products, (No Diagnostic Substances)
Headquarters
1000 Park Forty Plaza, Durham, NC 27713
Incorporated in
DE
Fiscal year ends
March
SEC CIK
0001764013

Recent SEC filings

Frequently asked questions

What is Immunovant's stock price?

Immunovant (IMVT) closed at $797.38 on Oct 9, 2026, up 0.49% from the previous close of $793.52.

What is Immunovant's market cap?

Immunovant's market cap is $164.47B, based on a share price of $797.38 and 206.3M shares outstanding as of Jun 30, 2026.

Does Immunovant pay a dividend?

Immunovant's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Immunovant, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures